On Thursday, Shares of Great Basin Scientific Inc (NASDAQ:GBSN), subtract -12.12% and closed at $0.290 in the last trading session. The last trading range of the stock ranges between $0.28and $0.40. Great Basin Scientific, Inc. (GBSN), a molecular diagnostics company, declared recently the U.S. and European commercial launch of its Staph ID/R Blood Culture Panel, the Company’s first multiplex panel. This sample-to-result, automated panel benefits hospitals and laboratories by detecting, in about two hours, bloodstream infections caused by MRSA and other Staphylococcus species, enabling accurate, timely, and cost-effective diagnosis and treatment of patients. The panel detects the mecA gene, a major drug resistance marker that confers resistance to methicillin and other beta-lactams and creates the superbug MRSA. The assay is unique in its ability to distinguish Coagulase-negative Staphylococci (CoNS), which may not require treatment with antibiotics, from pathogenic Staphylococci, and can therefore assist healthcare organizations with antimicrobial stewardship programs and campaigns.
“The commercial launch of our Staph ID/R Blood Culture Panel marks a major milestone in our growth as a company as we deliver on our unique capability of providing low-plex, direct-from-specimen and multiplex testing on a single platform,” said Ryan Ashton, co-founder and chief executive officer of Great Basin Scientific. “In Addition To, we’re happy to be able to offer a noteworthytool for hospitals and labs as they implement antimicrobial stewardship programs into their broader healthcare strategy. The need for a solution to assist clinicians battle antibiotic resistance is so great, nearly half of our installed customer base has already expressed an interest in our Staph ID/R Blood Culture Panel. Further, this panel is opening doors for our sales team at new larger sites not formerly open to the Great Basin platform. Our Staph ID/R Blood Culture Panel will allow the clinical laboratory to play an important role in achieving the antimicrobial stewardship aims of improving patient care, reducing costs, and combating emerging antimicrobial resistance.”
MGM Resorts International (NYSE:MGM), jumped 0.60 % and closed at $26.80 in the last trading session. The last trading range of the stock ranges between $26.56 and $27.04. The company’s Market capitalization is $15.40 Billion with the total Outstanding Shares of 565.61 Million. Chocolate-lovers beware! Zombies in search of their next victim haunt Jean Philippe Pâtisserie at Bellagio and ARIA with Halloween-themed displays at both iconic pastry shop locations. From gory and gruesome body parts to whimsical cakes and pastries, the displays cater to every guest, no matter how they prefer to celebrate the holiday. Executive Pastry Chef Claude Escamilla and his talented team worked diligently for eight months to create more than 45 festive showpieces that place the undead at center stage. With a year of planning, countless sketches and hundreds of ideas from skilled pastry artists, the final display showcases their hard work through a cake closely resembling human flesh, tombstones straight out of a horror movie and many more hair-raising pieces.
“I was very much inspired by my favorite TV program, “The Walking Dead,” said Escamilla. “When I was watching the show, I kept thinking about how I could take the characters and turn them into life-size creations for the holiday.”
ARIA’s main showpiece is a 200-pound, six-foot-tall male zombie made out of chocolate and rolling fondant. Because of his bold, statuesque position near the shop, guests are encouraged to take goosebump-worthy selfies with him if they dare. Another sight to behold is the life-size skeleton perched in a chocolate electric chair. This design took the team more than 70 hours to complete, using about 130 pounds of white and dark chocolate.
Monsanto Company (NYSE:MON), gained 0.31 % and closed at $103.50 in the last trading session. The last trading range of the stock ranges between $103.20 and $103.77. During the 52-week trading session the minimum price at which share price traded, registered at $83.73 and reached to max level of $114.26. Monsanto Company, together with its auxiliaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. The Seeds and Genomics segment produces raw crop seeds, counting corn, soybean, cotton, and canola seeds under the DEKALB, Channel, Asgrow, and Deltapine brands; and vegetable seeds, such as tomato, pepper, melon, cucumber, squash, beans, broccoli, onions, lettuce, and others under the Seminis and De Ruiter brands. It also develops biotechnology traits that assist farmers in controlling insects and weeds in corn, soybean, cotton, and canola crops under the SmartStax, YieldGard, YieldGard VT Triple, VT Triple PRO, and VT Double PRO brands; and Intacta RR2 PRO, and Bollgard and Bollgard II, in addition to Roundup Ready and Roundup Ready 2 Yield, and Genuity brands. This segment also licenses a range of germplasm and trait technologies to large and small seed companies. The Agricultural Productivity segment manufactures and sells herbicides for agricultural, industrial, ornamental, turf, and residential lawn and garden applications for weed control, in addition to for control of preemergent annual grass and small seeded broadleaf weeds in corn and other crops under the Roundup and Harness brands. The company markets its products through distributors, independent retailers and dealers, agricultural cooperatives, plant raisers, and agents, in addition to directly to farmers. Monsanto Company has a collaborative agreement with Novozymes to discover, develop, and produce microbial solutions.